Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies

ObjectivesTo evaluate and compare the performances of five commercial ELISA assays (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG. Methods70 negative control samples (collected before the COVID-19 pandemic) and samples from 101 RT-PCR-confirmed SARS-CoV-2 patients (c...

Full description

Saved in:
Bibliographic Details
Main Author: Hadi M., Yassine (author)
Other Authors: Al-Jighefee, Hadeel (author), Al-Sadeq, Duaa W. (author), Dargham, Soha R. (author), Younes, Salma N. (author), Shurrab, Farah (author), Marei, Reham M. (author), Hssain, Ali Ait (author), Taleb, Sara (author), Alhussain, Hashim A. (author), Al-Nesf, Maryiam A. (author), Al-Khal, Abdullatif (author), Qotba, Hamda (author), Althani, Asmaa A. (author), Tang, Patrick (author), Abu-Raddad, Laith J. (author), Nasrallah, Gheyath K. (author)
Format: article
Published: 2020
Subjects:
Online Access:http://dx.doi.org/10.1016/j.ijid.2020.10.042
https://www.sciencedirect.com/science/article/pii/S1201971220322463?v=s5
http://hdl.handle.net/10576/16855
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1857415083860164608
author Hadi M., Yassine
author2 Al-Jighefee, Hadeel
Al-Sadeq, Duaa W.
Dargham, Soha R.
Younes, Salma N.
Shurrab, Farah
Marei, Reham M.
Hssain, Ali Ait
Taleb, Sara
Alhussain, Hashim A.
Al-Nesf, Maryiam A.
Al-Khal, Abdullatif
Qotba, Hamda
Althani, Asmaa A.
Tang, Patrick
Abu-Raddad, Laith J.
Nasrallah, Gheyath K.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Hadi M., Yassine
Al-Jighefee, Hadeel
Al-Sadeq, Duaa W.
Dargham, Soha R.
Younes, Salma N.
Shurrab, Farah
Marei, Reham M.
Hssain, Ali Ait
Taleb, Sara
Alhussain, Hashim A.
Al-Nesf, Maryiam A.
Al-Khal, Abdullatif
Qotba, Hamda
Althani, Asmaa A.
Tang, Patrick
Abu-Raddad, Laith J.
Nasrallah, Gheyath K.
author_role author
dc.creator.none.fl_str_mv Hadi M., Yassine
Al-Jighefee, Hadeel
Al-Sadeq, Duaa W.
Dargham, Soha R.
Younes, Salma N.
Shurrab, Farah
Marei, Reham M.
Hssain, Ali Ait
Taleb, Sara
Alhussain, Hashim A.
Al-Nesf, Maryiam A.
Al-Khal, Abdullatif
Qotba, Hamda
Althani, Asmaa A.
Tang, Patrick
Abu-Raddad, Laith J.
Nasrallah, Gheyath K.
dc.date.none.fl_str_mv 2020-11-03T04:54:33Z
2020-10-27
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://dx.doi.org/10.1016/j.ijid.2020.10.042
Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain HA, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2020 Oct 27:S1201-9712(20)32246-3. doi: 10.1016/j.ijid.2020.10.042. Epub ahead of print. PMID: 33127504; PMCID: PMC7590641.
12019712
https://www.sciencedirect.com/science/article/pii/S1201971220322463?v=s5
http://hdl.handle.net/10576/16855
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Elsevier
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv COVID-19
SARS-CoV-2
Serology
IgG
ELISA
Sensitivity
Specificity
dc.title.none.fl_str_mv Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description ObjectivesTo evaluate and compare the performances of five commercial ELISA assays (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG. Methods70 negative control samples (collected before the COVID-19 pandemic) and samples from 101 RT-PCR-confirmed SARS-CoV-2 patients (collected at different time points from symptoms onset: ≤7, 8-14, and >14 days) were used to compare the sensitivity, specificity, agreement, positive and negative predictive values of each assay with RT-PCR. A concordance assessment between the five assays was also conducted. Cross-reactivity with other HCoV, non-HCoV respiratory viruses, non-respiratory viruses, and nuclear antigens was investigated. ResultsLionex showed the highest specificity (98.6%, 95%CI: 92.3-99.8), followed by EDI and Dia.Pro (97.1%, 95%CI: 90.2-99.2), NovaTec (85.7%, 95%CI: 75.7-92.1), then AnshLabs (75.7%, 95%CI: 64.5-84.2). All ELISA kits cross-reacted with one anti-MERS IgG positive sample except Lionex. The sensitivity was low during the early stages of the disease but improved over time. After 14 days from symptoms onset, Lionex and NovaTec showed the highest sensitivity at 87.9% (95%CI: 72.7-95.2) and 86.4% (95%CI: 78.5-91.7), respectively. The agreement with RT-PCR results based on Cohen’s kappa was as follows: Lionex (0.89)> NovaTec (0.70)> Dia.Pro (0.69)> AnshLabs (0.63)> EDI (0.55). ConclusionThe Lionex ELISA, which measures antibodies solely to the S1 protein, demonstrated the best performance.
eu_rights_str_mv openAccess
format article
id qu_f3ab81fd2bc84aa0959d4ac66fcb3170
identifier_str_mv Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain HA, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2020 Oct 27:S1201-9712(20)32246-3. doi: 10.1016/j.ijid.2020.10.042. Epub ahead of print. PMID: 33127504; PMCID: PMC7590641.
12019712
language_invalid_str_mv en
network_acronym_str qu
network_name_str Qatar University repository
oai_identifier_str oai:qspace.qu.edu.qa:10576/16855
publishDate 2020
publisher.none.fl_str_mv Elsevier
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
spelling Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodiesHadi M., YassineAl-Jighefee, HadeelAl-Sadeq, Duaa W.Dargham, Soha R.Younes, Salma N.Shurrab, FarahMarei, Reham M.Hssain, Ali AitTaleb, SaraAlhussain, Hashim A.Al-Nesf, Maryiam A.Al-Khal, AbdullatifQotba, HamdaAlthani, Asmaa A.Tang, PatrickAbu-Raddad, Laith J.Nasrallah, Gheyath K.COVID-19SARS-CoV-2SerologyIgGELISASensitivitySpecificityObjectivesTo evaluate and compare the performances of five commercial ELISA assays (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG. Methods70 negative control samples (collected before the COVID-19 pandemic) and samples from 101 RT-PCR-confirmed SARS-CoV-2 patients (collected at different time points from symptoms onset: ≤7, 8-14, and >14 days) were used to compare the sensitivity, specificity, agreement, positive and negative predictive values of each assay with RT-PCR. A concordance assessment between the five assays was also conducted. Cross-reactivity with other HCoV, non-HCoV respiratory viruses, non-respiratory viruses, and nuclear antigens was investigated. ResultsLionex showed the highest specificity (98.6%, 95%CI: 92.3-99.8), followed by EDI and Dia.Pro (97.1%, 95%CI: 90.2-99.2), NovaTec (85.7%, 95%CI: 75.7-92.1), then AnshLabs (75.7%, 95%CI: 64.5-84.2). All ELISA kits cross-reacted with one anti-MERS IgG positive sample except Lionex. The sensitivity was low during the early stages of the disease but improved over time. After 14 days from symptoms onset, Lionex and NovaTec showed the highest sensitivity at 87.9% (95%CI: 72.7-95.2) and 86.4% (95%CI: 78.5-91.7), respectively. The agreement with RT-PCR results based on Cohen’s kappa was as follows: Lionex (0.89)> NovaTec (0.70)> Dia.Pro (0.69)> AnshLabs (0.63)> EDI (0.55). ConclusionThe Lionex ELISA, which measures antibodies solely to the S1 protein, demonstrated the best performance.This work was made possible by grant No. RRC-2-032 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. GKN would like to acknowledge funds from Qatar University's internal grant QUERG-CMED-2020-2.Elsevier2020-11-03T04:54:33Z2020-10-27Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.1016/j.ijid.2020.10.042Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain HA, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2020 Oct 27:S1201-9712(20)32246-3. doi: 10.1016/j.ijid.2020.10.042. Epub ahead of print. PMID: 33127504; PMCID: PMC7590641.12019712https://www.sciencedirect.com/science/article/pii/S1201971220322463?v=s5http://hdl.handle.net/10576/16855enhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:qspace.qu.edu.qa:10576/168552024-07-23T11:23:07Z
spellingShingle Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
Hadi M., Yassine
COVID-19
SARS-CoV-2
Serology
IgG
ELISA
Sensitivity
Specificity
status_str publishedVersion
title Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
title_full Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
title_fullStr Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
title_full_unstemmed Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
title_short Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
title_sort Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
topic COVID-19
SARS-CoV-2
Serology
IgG
ELISA
Sensitivity
Specificity
url http://dx.doi.org/10.1016/j.ijid.2020.10.042
https://www.sciencedirect.com/science/article/pii/S1201971220322463?v=s5
http://hdl.handle.net/10576/16855